-
1
-
-
58049157203
-
Second-generation versus first-generation antipsychotic drugs for schizophrenia: A meta-analysis
-
Leucht S, Corves C, Arbter D, et al. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet. 2009; 373: 31-41.
-
(2009)
Lancet
, vol.373
, pp. 31-41
-
-
Leucht, S.1
Corves, C.2
Arbter, D.3
-
2
-
-
84878877318
-
Efficacy and safety of individual second-generation vs. First-generation antipsychotics in first-episode psychosis: A systematic review and meta-analysis
-
Zhang JP, Gallego JA, Robinson DG, et al. Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis. Int J Neuropsychopharmacol. 2013; 16: 1205-1218.
-
(2013)
Int J Neuropsychopharmacol
, vol.16
, pp. 1205-1218
-
-
Zhang, J.P.1
Gallego, J.A.2
Robinson, D.G.3
-
3
-
-
0029046408
-
Treatment of schizophrenia
-
Kane JM, McGlashan TH. Treatment of schizophrenia. Lancet. 1995; 346: 820-825.
-
(1995)
Lancet
, vol.346
, pp. 820-825
-
-
Kane, J.M.1
McGlashan, T.H.2
-
4
-
-
33845592951
-
Adverse effects of atypical antipsychotics in the elderly. A review
-
Gareri P, Fazio PD, Fazio SD, et al. Adverse effects of atypical antipsychotics in the elderly. A review. Drugs Aging. 2006; 23: 937-956.
-
(2006)
Drugs Aging
, vol.23
, pp. 937-956
-
-
Gareri, P.1
Fazio, P.D.2
Fazio, S.D.3
-
5
-
-
84897991128
-
Adverse effects associated with second-generation antipsychotic long-acting injection treatment: A Comprehensive Systematic Review
-
Gentile S. Adverse effects associated with second-generation antipsychotic long-acting injection treatment: A Comprehensive Systematic Review. Pharmacotherapy. 2013; 33: 1087-1106.
-
(2013)
Pharmacotherapy
, vol.33
, pp. 1087-1106
-
-
Gentile, S.1
-
6
-
-
78751691883
-
Increasing off-label use of antipsychotics medications in the United States. 1995-2008
-
Alexander GC, Gallagher SA, Mascola A, et al. Increasing off-label use of antipsychotics medications in the United States. 1995-2008. Pharmacoepidemiol Drug Saf. 2011; 20: 177-184.
-
(2011)
Pharmacoepidemiol Drug Saf
, vol.20
, pp. 177-184
-
-
Alexander, G.C.1
Gallagher, S.A.2
Mascola, A.3
-
7
-
-
84857167127
-
Antipsychotic Medication Prescribing Trends in Children and Adolescents
-
Harrison JN, Cluxton-Keller F, Gross D. Antipsychotic Medication Prescribing Trends in Children and Adolescents. J Pediatr Health Care. 2012; 2: 139-145.
-
(2012)
J Pediatr Health Care
, vol.2
, pp. 139-145
-
-
Harrison, J.N.1
Cluxton-Keller, F.2
Gross, D.3
-
8
-
-
44449097249
-
Epidemiologic features of antipsychotic prescribing to children and adolescents in primary care in the United Kingdom
-
Rani F, Murray ML, Byrn PJ, et al. Epidemiologic features of antipsychotic prescribing to children and adolescents in primary care in the United Kingdom. Pediatrics. 2008; 121: 1002-1009.
-
(2008)
Pediatrics
, vol.121
, pp. 1002-1009
-
-
Rani, F.1
Murray, M.L.2
Byrn, P.J.3
-
9
-
-
59049100725
-
Pediatric drug surveillance and the Food and Drug Administration’s adverse event reporting system: An overview of reports. 2003-2007
-
Johann-Liang R, Wyeth J, Chen M, et al. Pediatric drug surveillance and the Food and Drug Administration’s adverse event reporting system: an overview of reports. 2003-2007. Pharmacoepidemiol Drug Saf. 2009; 18(1):24-27.
-
(2009)
Pharmacoepidemiol Drug Saf
, vol.18
, Issue.1
, pp. 24-27
-
-
Johann-Liang, R.1
Wyeth, J.2
Chen, M.3
-
10
-
-
0035700740
-
Use of Proportional Reporting Ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports
-
Evans SJ, Waller PC, Davis S. Use of Proportional Reporting Ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf, 2001; 10: 483-486.
-
(2001)
Pharmacoepidemiol Drug Saf
, vol.10
, pp. 483-486
-
-
Evans, S.J.1
Waller, P.C.2
Davis, S.3
-
11
-
-
0036210975
-
A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions
-
Van Puijenbroek EP, Bate A, Leufkens HG, et al. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol Drug Saf. 2002; 11: 3-10.
-
(2002)
Pharmacoepidemiol Drug Saf
, vol.11
, pp. 3-10
-
-
Van Puijenbroek, E.P.1
Bate, A.2
Leufkens, H.G.3
-
12
-
-
0031871338
-
A Bayesian neural network method for adverse drug reaction signal generation
-
Bate A, Lindquist M, Edwards IR, et al. A Bayesian neural network method for adverse drug reaction signal generation. Eur J Clin Pharmacol. 1998; 54:315-321.
-
(1998)
Eur J Clin Pharmacol
, vol.54
, pp. 315-321
-
-
Bate, A.1
Lindquist, M.2
Edwards, I.R.3
-
13
-
-
0036300732
-
Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA’s spontaneous reports database
-
Szarfman A, Machao SG, O’Neill RT. Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA’s spontaneous reports database. Drug Saf. 2002; 25: 381-392.
-
(2002)
Drug Saf
, vol.25
, pp. 381-392
-
-
Szarfman, A.1
Machao, S.G.2
O’Neill, R.T.3
-
14
-
-
68149124572
-
Quantitative signal detection using spontaneous ADR reporting
-
Bate A, Evans SJ. Quantitative signal detection using spontaneous ADR reporting. Pharmacoepidemiol Drug Saf. 2009; 18: 427-436.
-
(2009)
Pharmacoepidemiol Drug Saf
, vol.18
, pp. 427-436
-
-
Bate, A.1
Evans, S.J.2
-
15
-
-
9144239875
-
Drug-induced pancreatitis: Lessons in data mining
-
Hauben M, Reich L. Drug-induced pancreatitis: lessons in data mining. Br J Clin Pharmacol. 2004; 58: 560-562.
-
(2004)
Br J Clin Pharmacol
, vol.58
, pp. 560-562
-
-
Hauben, M.1
Reich, L.2
-
16
-
-
26944491481
-
Perspectives on the use of data mining in pharmacovigilance
-
Almenoff J, Tonning JM, Gould AL, et al. Perspectives on the use of data mining in pharmacovigilance. Drug Saf. 2005; 28: 981-1007.
-
(2005)
Drug Saf
, vol.28
, pp. 981-1007
-
-
Almenoff, J.1
Tonning, J.M.2
Gould, A.L.3
-
17
-
-
34447520376
-
Novel statistical tools for monitoring the safety of marketed drugs
-
Almenoff JS, Pattishall EN, Gibbs TG, et al. Novel statistical tools for monitoring the safety of marketed drugs. Clin Pharmacol Ther. 2007; 82: 157-166.
-
(2007)
Clin Pharmacol Ther
, vol.82
, pp. 157-166
-
-
Almenoff, J.S.1
Pattishall, E.N.2
Gibbs, T.G.3
-
18
-
-
62849083003
-
Decision support methods for the detection of adverse events in post-marketing data
-
Hauben M, Bate A. Decision support methods for the detection of adverse events in post-marketing data. Drug Discov Today. 2009; 14: 343-357.
-
(2009)
Drug Discov Today
, vol.14
, pp. 343-357
-
-
Hauben, M.1
Bate, A.2
-
20
-
-
69549114805
-
Neuroleptic malignant syndrome in children and adolescents on atypical antipsychotic medication: A review
-
Neuhut R, Lindenmayer JP, Silva R. Neuroleptic malignant syndrome in children and adolescents on atypical antipsychotic medication: A review. J Child Adolesc Psychopharmacol. 2009; 19: 415-422.
-
(2009)
J Child Adolesc Psychopharmacol
, vol.19
, pp. 415-422
-
-
Neuhut, R.1
Lindenmayer, J.P.2
Silva, R.3
-
21
-
-
84880540083
-
Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: Theoretical background and practical recommendations
-
Cerovecki A, Musil R, Klimke A, et al. Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendations. CNS Drugs. 2013; 27: 545-572.
-
(2013)
CNS Drugs
, vol.27
, pp. 545-572
-
-
Cerovecki, A.1
Musil, R.2
Klimke, A.3
-
22
-
-
84869084282
-
Toxicology and overdose of atypical antipsychotics
-
Minns AB, Clark RF. Toxicology and overdose of atypical antipsychotics. J Emerg Med. 2012; 43: 906-913.
-
(2012)
J Emerg Med
, vol.43
, pp. 906-913
-
-
Minns, A.B.1
Clark, R.F.2
-
23
-
-
77649273872
-
QTc prolongation and antipsychotic medications in a sample of 1017 patients with schizophrenia
-
Ozeki Y, Fujii K, Kurimoto N, et al. QTc prolongation and antipsychotic medications in a sample of 1017 patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2010; 34: 401-405.
-
(2010)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.34
, pp. 401-405
-
-
Ozeki, Y.1
Fujii, K.2
Kurimoto, N.3
-
24
-
-
84878698751
-
Antipsychotics and torsadogenic risk: Signals emerging from the US FDA Adverse Event Reporting System database
-
Poluzzi E, Raschi E, Koci A, et al. Antipsychotics and torsadogenic risk: signals emerging from the US FDA Adverse Event Reporting System database. Drug Saf. 2013; 36: 467-479.
-
(2013)
Drug Saf
, vol.36
, pp. 467-479
-
-
Poluzzi, E.1
Raschi, E.2
Koci, A.3
-
25
-
-
82155164409
-
QTc prolongation by psychotropic drugs and the risk of torsade de pointes
-
Wenzel-Seifert K, Wittmann M, Haen E. QTc prolongation by psychotropic drugs and the risk of torsade de pointes. Dtsch Arztebl Int. 2011; 108: 687-693.
-
(2011)
Dtsch Arztebl Int
, vol.108
, pp. 687-693
-
-
Wenzel-Seifert, K.1
Wittmann, M.2
Haen, E.3
-
26
-
-
84875447775
-
Risk factors for neutropenia in clozapine-treated children and adolescents with childhood-onset schizophrenia
-
Maher KN, Tan M, Tossell JW, et al. Risk factors for neutropenia in clozapine-treated children and adolescents with childhood-onset schizophrenia. J child adolesc psychopharmacol. 2013; 23: 110-116.
-
(2013)
J Child Adolesc Psychopharmacol
, vol.23
, pp. 110-116
-
-
Maher, K.N.1
Tan, M.2
Tossell, J.W.3
-
27
-
-
84892535501
-
Systematic review of the efficacy and tolerability of Clozapine in the treatment of youth with early onset schizophrenia
-
Schneider C, Corrigall R, Hayes D, et al. Systematic review of the efficacy and tolerability of Clozapine in the treatment of youth with early onset schizophrenia. Eur Psychiatry. 2014; 29: 1-10.
-
(2014)
Eur Psychiatry
, vol.29
, pp. 1-10
-
-
Schneider, C.1
Corrigall, R.2
Hayes, D.3
-
28
-
-
84872421868
-
Risperidone-induced leucopenia: A case report and brief review of literature
-
Manfredi G, Solfanelli A, Dimitri G, et al. Risperidone-induced leucopenia: a case report and brief review of literature. Gen Hosp Psychiatry. 2013; 35: 102.e3-102.e6.
-
(2013)
Gen Hosp Psychiatry
, vol.35
, pp. e3-e6
-
-
Manfredi, G.1
Solfanelli, A.2
Dimitri, G.3
-
29
-
-
0033711684
-
A case of leukopenia in treatment with risperidone in an adolescent
-
Etain B, Roubaud L, Le Heuzey MF et al. A case of leukopenia in treatment with risperidone in an adolescent. Encepahle. 2000; 26: 81-84.
-
(2000)
Encepahle
, vol.26
, pp. 81-84
-
-
Etain, B.1
Roubaud, L.2
Le Heuzey, M.F.3
-
30
-
-
0037227192
-
Clozapine treatment for suicidality in schizopherenia: Internal Suicide Prevention Trial
-
Meltzer HY, Alphs L, Green AI et al. Clozapine treatment for suicidality in schizopherenia: Internal Suicide Prevention Trial. Arch Gen Psychiatry. 2003; 60: 82-91.
-
(2003)
Arch Gen Psychiatry
, vol.60
, pp. 82-91
-
-
Meltzer, H.Y.1
Alphs, L.2
Green, A.I.3
-
31
-
-
68949172254
-
11-year Follow-Up of Mortality in Patients with Schizophrenia: A Population-Based Cohort Study (FIN11 Study)
-
Tiihonen J, Loonqvist J, Wahlbeck K, et al. 11-year Follow-Up of Mortality in Patients with Schizophrenia: A Population-Based Cohort Study (FIN11 Study). Lancet. 2009; 374: 620-627.
-
(2009)
Lancet
, vol.374
, pp. 620-627
-
-
Tiihonen, J.1
Loonqvist, J.2
Wahlbeck, K.3
-
32
-
-
77958198145
-
Suicide attempts in a prospective cohort of patients with schizophrenia treated with Sertindole or Riperidone
-
Crocq MA, Naber D, Lader MH, et al. Suicide attempts in a prospective cohort of patients with schizophrenia treated with Sertindole or Riperidone. Eur Neuropsychopharmaco. 2010; 20: 829-838.
-
(2010)
Eur Neuropsychopharmaco
, vol.20
, pp. 829-838
-
-
Crocq, M.A.1
Naber, D.2
Lader, M.H.3
-
33
-
-
48249105115
-
Association between medication and Risk of suicide, attempted suicide and death in nationwide cohort of suicidal patients with schizophrenia
-
Haukka J, Tiihonen J, Harkanen T, et al. Association between medication and Risk of suicide, attempted suicide and death in nationwide cohort of suicidal patients with schizophrenia. Pharmacoepidemiol Drug Saf. 2008; 17: 686-696.
-
(2008)
Pharmacoepidemiol Drug Saf
, vol.17
, pp. 686-696
-
-
Haukka, J.1
Tiihonen, J.2
Harkanen, T.3
|